Articles
 News Headlines
 Journal Headlines

  Home
  Archives
  Site Map
   
May 9, 2008
 
About AIDScience
Contact Us
——
NeuroAIDS
 
 
 
 

Vol. 2, No. 16, 9 August 2002
Other Issues:
AIDScience Perspective:
From Science:
HIV/AIDS: Malawi: A suitable case for treatment
by Jon Cohen.
[Full text article]  [About AIDScience articles]  [See recent AIDScience articles]
[See other Cohen articles]  [dEbates: Submit a response to this article]
Hot News:
Could widespread use of combination antiretroviral therapy eradicate HIV epidemics? Using uncertainty analysis, a new model predicts that current combination antiretroviral therapies could eventually eradicate the HIV epidemic. The probability was even better if risky sexual behavior was reduced.
Lancet Infectious Diseases 2(8), 1 August 2002 [Read paper]
Related article:
Number-crunching suggests AIDS could die out in San Francisco.
San Francisco Chronicle, 1 August 2002 [Read article]

Molecular epidemiology of HIV-1 genetic forms and its significance for vaccine development and therapy. Twenty-four circulating genetic forms of the main HIV-1 group have been recognized, including 11 subtypes or sub-subtypes and 13 circulating recombinant forms, but the significance of these genetic forms for vaccine design and new therapeutic strategies has not been defined.
Lancet Infectious Diseases 2(8), 1 August 2002 [Read abstract] (full paper requires registration)

Gene transfer of human monoclonal antibodies generates neutralizing activity against HIV-1 in serum. A recombinant adeno-associated virus (rAAV) vector was used to deliver the gene for the human antibody IgG1b12 to mouse muscle. Significant levels of HIV-neutralizing activity were found in the sera of mice for over 6 months after a single intramuscular administration of the rAAV vector.
Journal of Virology 76(17), September 2002 [Read abstract] (full paper requires registration)

ADODB.Connection error '800a0e7a'

Provider cannot be found. It may not be properly installed.

/Issues/Issue033.asp, line 84

Latest News Headlines: [What is this?]